United States · FDA National Drug Code directory
WEZLANA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84612-055_4feadcb0-90b7-4e84-90c2-2eaaa8868ca8
- Product NDC
- 84612-055
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ustekinumab-auub
- Labeler
- Nuvaila Limited
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250101
- Source listing expiry
- 20271231
Source-listed ingredients
- USTEKINUMAB — 45 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (84612-055-01) / .5 mL in 1 VIAL · 84612-055-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →